MedPath

ABBOTT-RABEPRAZOLE

ABBOTT-RABEPRAZOLE

Discontinued
DIN Number

02422638

Drug Class

Human

Market Date

Oct 17, 2014

Company
HC

BGP Pharma ULC

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02422638
AIG Number0143681001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A02BC04 RABEPRAZOLE
Product Specifications
Dosage FormTablet (Delayed-Release)
Route of AdministrationOral
AHFS Classification56:28.36
Health Canada Classification

ACTIVE INGREDIENTS (1)

RABEPRAZOLE SODIUMActive
Strength: 10 MG
Monograph: RABEPRAZOLE SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.